AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33530713 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 110
Study 35834762 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy followed by autologous stem-cell transplantation (ASCT)
Number of subjects: 97
Study 35834762 — intervention group
Group type: COMPARATOR
Intervention: Whole-brain radiotherapy (WBRT)
Number of subjects: 97
Study 35834762 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 97
Study 34372561 — intervention group
Group type: EXPERIMENTAL
Intervention: nOPV2 candidates
Number of subjects: 49
Study 35439775 — intervention group
Group type: EXPERIMENTAL
Intervention: Blepharoexfoliation with tea tree oil 2% shampoo followed by eyelid scrubs with tea tree oil 2% shampoo twice a day for 8 weeks
Number of subjects: 81
Study 35439775 — intervention group
Group type: COMPARATOR
Intervention: Control group with sham blepharoexfoliation and eyelid scrubs with tea tree oil 2% shampoo twice a day for 8 weeks
Number of subjects: 81
Study 35439775 — intervention group
Group type: EXPERIMENTAL
Intervention: Blepharoexfoliation group
Number of subjects: 81
Study 35439775 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study 35439775 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study 33440080 — intervention group
Group type: EXPERIMENTAL
Intervention: Fotagliptin (24 mg, once-daily for 14 days)
Number of subjects: 14
Study 33440080 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once-daily for 14 days)
Number of subjects: 14
Study 33302666 — intervention group
Group type: EXPERIMENTAL
Intervention: Permissive hypercapnia (PHC) ventilation strategy, maintaining PaCO2 at 46-60 mmHg.
Number of subjects: 66
Study 33302666 — intervention group
Group type: EXPERIMENTAL
Intervention: Permissive hypercapnia (PHC) ventilation strategy.
Number of subjects: 66
Study 33302666 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (Group C).
Number of subjects: 66
Study 35099523 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent vaccine campaign
Number of subjects: 7496
Study 35099523 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 7496
Study 33299880 — intervention group
Group type: EXPERIMENTAL
Intervention: High C-reactive protein-to-albumin ratio (CAR)
Number of subjects: 676
Study 33299880 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 676
Study 33299880 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration curve
Number of subjects: 676
Study 33299880 — intervention group
Group type: EXPERIMENTAL
Intervention: CAR, CEA, lymph node metastasis, operation mode, perineural invasion
Number of subjects: 676
Study 34580419 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 36
Study 34580419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 32070905 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit tax (20% higher post-tax prices)
Number of subjects: 941
Study 32070905 — intervention group
Group type: EXPERIMENTAL
Intervention: Fake tax (pre-tax prices with a false 20% tax label)
Number of subjects: 941
Study 32070905 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit tax (actual 20% price increase with a false tax label)
Number of subjects: 941
Study 32070905 — intervention group
Group type: COMPARATOR
Intervention: Control (no tax)
Number of subjects: 941
Study 35575751 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop therapy (MiniMed 670G)
Number of subjects: 0
Study 34410322 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 12 weeks, thrice-weekly, supervised aerobic sessions at 85% to 95% of peak oxygen consumption (V̇o2)
Number of subjects: 52
Study 34410322 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 52
Study 34410322 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 52
Study 32271150 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention for weekly monitoring of side effects using PRO-CTCAE questions
Number of subjects: 57
Study 32271150 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention for weekly monitoring of side effects
Number of subjects: 57
Study 34341833 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 179
Study 34341833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study 34646885 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Implant Placement (IIP)
Number of subjects: 50
Study 34646885 — intervention group
Group type: COMPARATOR
Intervention: Delayed Implant Placement (DIP)
Number of subjects: 50
Study 34232693 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound biofeedback
Number of subjects: 7
Study 34232693 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-acoustic biofeedback
Number of subjects: 7
Study 32654884 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned Pain Modulation (CPM)
Number of subjects: 36
Study 32654884 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting EEG (alpha and beta power)
Number of subjects: 36
Study 32654884 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-Related Desynchronization (ERD) in theta and delta bands
Number of subjects: 36
Study 32654884 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracortical inhibition and facilitation ratios
Number of subjects: 36
Study 32654884 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-Related Desynchronization (ERD) in delta band
Number of subjects: 36
Study 35772133 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS)
Number of subjects: 29
Study 35772133 — intervention group
Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 29
Study 32718746 — intervention group
Group type: EXPERIMENTAL
Intervention: sEMG-BFB (n = 19)
Number of subjects: 38
Study 32718746 — intervention group
Group type: COMPARATOR
Intervention: Sham BFB (n = 19)
Number of subjects: 38
Study 32799997 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based contraceptive clinic (SBCC)
Number of subjects: 0
Study 32799997 — intervention group
Group type: EXPERIMENTAL
Intervention: Legal statutes and policies
Number of subjects: 0
Study 32799997 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistical considerations
Number of subjects: 0
Study 35226725 — intervention group
Group type: EXPERIMENTAL
Intervention: Penehyclidine inhalation
Number of subjects: 864
Study 35226725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 864
Study 32005206 — intervention group
Group type: EXPERIMENTAL
Intervention: Disabled People's Organisations (DPOs) intervention with regular home visits and financial support for public events and exposure visits to other DPOs.
Number of subjects: 527
Study 32005206 — intervention group
Group type: EXPERIMENTAL
Intervention: Disabled People's Organisations (DPOs) intervention.
Number of subjects: 527
Study 35414527 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery (< 12 weeks after injury)
Number of subjects: 53
Study 35414527 — intervention group
Group type: COMPARATOR
Intervention: Regular wait time (≥ 12 weeks)
Number of subjects: 53
Study 35414527 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study 35229767 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional root canal therapy along with LLLT
Number of subjects: 40
Study 35229767 — intervention group
Group type: COMPARATOR
Intervention: Conventional root canal therapy only
Number of subjects: 40
Study 32751340 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal treatment in conjunction with ozone gas therapy
Number of subjects: 100
Study 32751340 — intervention group
Group type: COMPARATOR
Intervention: Standard periodontal treatment
Number of subjects: 100
Study 35267892 — intervention group
Group type: EXPERIMENTAL
Intervention: TRM30 (30% TRM replacement)
Number of subjects: 39
Study 35267892 — intervention group
Group type: COMPARATOR
Intervention: Original formula (tapioca maltodextrin)
Number of subjects: 39
Study 35267892 — intervention group
Group type: EXPERIMENTAL
Intervention: TRM15 (15% TRM replacement)
Number of subjects: 39
Study 35267892 — intervention group
Group type: COMPARATOR
Intervention: Control (original formula)
Number of subjects: 39
Study 33054113 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (200mg)
Number of subjects: 28
Study 33054113 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron sucrose (200mg)
Number of subjects: 28
Study 33054113 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron isomaltoside 1000 (200mg)
Number of subjects: 28
Study 33054113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 32240016 — intervention group
Group type: EXPERIMENTAL
Intervention: IL (30% maximum inspiratory pressure)
Number of subjects: 8
Study 32240016 — intervention group
Group type: EXPERIMENTAL
Intervention: CUFF (80 mmHg)
Number of subjects: 8
Study 32240016 — intervention group
Group type: EXPERIMENTAL
Intervention: IL + CUFF
Number of subjects: 8
Study 32240016 — intervention group
Group type: COMPARATOR
Intervention: CTL (no intervention)
Number of subjects: 8
Study 32240016 — intervention group
Group type: EXPERIMENTAL
Intervention: IL
Number of subjects: 8
Study 32240016 — intervention group
Group type: EXPERIMENTAL
Intervention: CUFF
Number of subjects: 8
Study 35624525 — intervention group
Group type: EXPERIMENTAL
Intervention: Celery seed extract (1.34 g per day)
Number of subjects: 52
Study 35624525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 35624525 — intervention group
Group type: EXPERIMENTAL
Intervention: Celery seed extract
Number of subjects: 52
Study 33161045 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) - 4x4‐minute sessions, 3 times weekly for 4 weeks, followed by 3 home-based sessions weekly for 48 weeks
Number of subjects: 93
Study 33161045 — intervention group
Group type: COMPARATOR
Intervention: Moderate intensity continuous training (MICT) - 40 minutes, usual care, 3 times weekly for 4 weeks, followed by 3 home-based sessions weekly for 48 weeks
Number of subjects: 93
Study 32720367 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenestrated extracardiac Fontan (ECF-F), n = 20
Number of subjects: 40
Study 32720367 — intervention group
Group type: COMPARATOR
Intervention: Non-fenestrated extracardiac Fontan (ECF-NF), n = 20
Number of subjects: 40
Study 32720367 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenestrated extracardiac Fontan (ECF-F)
Number of subjects: 40
Study 32720367 — intervention group
Group type: COMPARATOR
Intervention: Non-fenestrated extracardiac Fontan (ECF-NF)
Number of subjects: 40
Study 34694179 — intervention group
Group type: COMPARATOR
Intervention: Opt-out group received Qvintip® sampling device by regular mail.
Number of subjects: 12000
Study 34694179 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-in group received Qvintip® self-sampler by e-mail invitation.
Number of subjects: 12000
Study 34694179 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-in group received Evalyn® Brush self-sampler by e-mail invitation.
Number of subjects: 12000
Study 34694179 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sampling acceptance.
Number of subjects: 12000
Study 33320764 — intervention group
Group type: EXPERIMENTAL
Intervention: Biocellulose with blue nanosilver dressing
Number of subjects: 20
Study 33320764 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine cream
Number of subjects: 20
Study 36382684 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at the lowest load (10 cmH2O)
Number of subjects: 40
Study 36382684 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 30% of maximal inspiratory pressure (MIP)
Number of subjects: 40
Study 36382684 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 34312146 — intervention group
Group type: EXPERIMENTAL
Intervention: SMARTHealth India intervention managed by ASHAs
Number of subjects: 18
Study 34312146 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 18
Study 32151697 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenotification SMS on the day of questionnaire mail-out
Number of subjects: 269
Study 32151697 — intervention group
Group type: COMPARATOR
Intervention: Postnotification SMS 4 days after questionnaire mail-out
Number of subjects: 269
Study 32151697 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenotification SMS
Number of subjects: 269
Study 32151697 — intervention group
Group type: COMPARATOR
Intervention: Postnotification SMS
Number of subjects: 269
Study 32151697 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of two RCTs
Number of subjects: 269
Study 36456937 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type‐A (BTX‐A)
Number of subjects: 27
Study 36456937 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT)
Number of subjects: 27
Study 36456937 — intervention group
Group type: COMPARATOR
Intervention: Anterior repositioning appliance (ARA)
Number of subjects: 27
Study 33857414 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg intravenously every 3 weeks for 1 year)
Number of subjects: 1019
Study 33857414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1019
Study 35310194 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling group (150 subjects)
Number of subjects: 200
Study 35310194 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (50 subjects)
Number of subjects: 200
Study 34108716 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine
Number of subjects: 383812
Study 34108716 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 (Pfizer–BioNTech) vaccine
Number of subjects: 383812
Study 34108716 — intervention group
Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 383812
Study 32787861 — intervention group
Group type: EXPERIMENTAL
Intervention: GigaPan®
Number of subjects: 614
Study 32787861 — intervention group
Group type: COMPARATOR
Intervention: Google Street View
Number of subjects: 614
Study 35261318 — intervention group
Group type: EXPERIMENTAL
Intervention: siponimod (2 mg/day)
Number of subjects: 1560
Study 35261318 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1560
Study 32114709 — intervention group
Group type: EXPERIMENTAL
Intervention: Subretinal injection of conbercept (0.5 mg/0.05 ml)
Number of subjects: 13
Study 32114709 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal injection of conbercept (0.5 mg/0.05 ml)
Number of subjects: 13
Study 33471086 — intervention group
Group type: EXPERIMENTAL
Intervention: HTX-011 (up to 60 mg bupivacaine/1.8 mg meloxicam) as the foundation of multimodal analgesia (MMA) regimen with ibuprofen (600 mg) and acetaminophen (1 g) every 3 hours for 72 hours.
Number of subjects: 31
Study 33471086 — intervention group
Group type: EXPERIMENTAL
Intervention: HTX-011 with scheduled ibuprofen and acetaminophen.
Number of subjects: 31
Study 36188178 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF)
Number of subjects: 20
Study 36188178 — intervention group
Group type: COMPARATOR
Intervention: Sham-Neurofeedback (sham-NF)
Number of subjects: 20
Study 36323991 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to Daily Occupational Performance (CO‐OP)
Number of subjects: 12
Study 36323991 — intervention group
Group type: COMPARATOR
Intervention: Conductive Education (CE)
Number of subjects: 12
Study 34143285 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac imaging (echocardiography, CT, MRI)
Number of subjects: 0
Study 32436048 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 62
Study 32436048 — intervention group
Group type: COMPARATOR
Intervention: IVF
Number of subjects: 62
Study 35710091 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) plus Compression Therapy (CT)
Number of subjects: 32
Study 35710091 — intervention group
Group type: EXPERIMENTAL
Intervention: Calf Muscle Exercise Training (CMET) plus Compression Therapy (CT)
Number of subjects: 32
Study 35710091 — intervention group
Group type: COMPARATOR
Intervention: Compression Therapy (CT) alone
Number of subjects: 32
Study 34258509 — intervention group
Group type: EXPERIMENTAL
Intervention: Odanacatib (anti‐cathepsin K monoclonal antibody)
Number of subjects: 0
Study 34258509 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab (anti‐sclerostin monoclonal antibody)
Number of subjects: 0
Study 34258509 — intervention group
Group type: COMPARATOR
Intervention: Bisphosphonates
Number of subjects: 0
Study 35549904 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam/pethidine combination
Number of subjects: 100
Study 35549904 — intervention group
Group type: COMPARATOR
Intervention: Midazolam alone
Number of subjects: 100
Study 34614745 — intervention group
Group type: EXPERIMENTAL
Intervention: MDI-QKD with NPRCS using different intensities of coherent states in key and test bases
Number of subjects: 0
Study 34614745 — intervention group
Group type: COMPARATOR
Intervention: MDI-QKD with NPRCS using same intensity of coherent states in key and test bases
Number of subjects: 0
Study 33793143 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine (3 g twice a day for 4 weeks)
Number of subjects: 20
Study 33793143 — intervention group
Group type: COMPARATOR
Intervention: Glucose (placebo, 3 g twice a day for 4 weeks)
Number of subjects: 20
Study 32115159 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational attainment
Number of subjects: 243
Study 32115159 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of service
Number of subjects: 243
Study 32115159 — intervention group
Group type: EXPERIMENTAL
Intervention: Average monthly income
Number of subjects: 243
Study 32115159 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of knowledge
Number of subjects: 243
Study 35655483 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological nursing methods
Number of subjects: 104
Study 35655483 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing of gynecological malignant tumor chemotherapy
Number of subjects: 104
Study 32030602 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score model based on predictors including age, preoperative sepsis, planned open procedure, estimated glomerular filtration rate, and preoperative albumin level.
Number of subjects: 68953
Study 32862577 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced glutathione (GSH) treatment
Number of subjects: 96
Study 32862577 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 96
Study 34371524 — intervention group
Group type: EXPERIMENTAL
Intervention: daridorexant 50 mg single dose
Number of subjects: 24
Study 34371524 — intervention group
Group type: COMPARATOR
Intervention: famotidine 40 mg single dose + daridorexant 50 mg single dose
Number of subjects: 24
Study 34371524 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz 600 mg once a day for 10 days
Number of subjects: 24
Study 34371524 — intervention group
Group type: EXPERIMENTAL
Intervention: daridorexant 50 mg single dose + efavirenz 600 mg once a day for 2 days
Number of subjects: 24
Study 33852465 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized dermal matrix and NPWT
Number of subjects: 30
Study 33852465 — intervention group
Group type: COMPARATOR
Intervention: Conventional NPWT
Number of subjects: 30
Study 35582884 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational application intervention
Number of subjects: 116
Study 35582884 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 116
Study 34964736 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 0
Study 34964736 — intervention group
Group type: COMPARATOR
Intervention: Oral mirtazapine (Control)
Number of subjects: 0
Study 35622185 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip plus optimal medical therapy (OMT)
Number of subjects: 0
Study 35622185 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT) alone
Number of subjects: 0
Study 33054556 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone (a catechol-O-methyltransferase inhibitor)
Number of subjects: 49
Study 33054556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 33149130 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐Rd (daratumumab/lenalidomide/dexamethasone)
Number of subjects: 569
Study 33149130 — intervention group
Group type: COMPARATOR
Intervention: Rd (lenalidomide/dexamethasone)
Number of subjects: 569
Study 35871013 — intervention group
Group type: EXPERIMENTAL
Intervention: STARKIDS intervention
Number of subjects: 1000
Study 35871013 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving a one-time structured counselling
Number of subjects: 1000
Study 33338896 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid suture and anchor-based capsular repair
Number of subjects: 18
Study 33338896 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional all-suture repair
Number of subjects: 18
Study 35543936 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp-nape acupuncture
Number of subjects: 42
Study 35543936 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical symptomatic treatment + NMES and rehabilitation training (Control group)
Number of subjects: 42
Study 35564820 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based psychological intervention (I-IG)
Number of subjects: 221
Study 35564820 — intervention group
Group type: EXPERIMENTAL
Intervention: Onsite intervention (part of I-IG)
Number of subjects: 221
Study 35564820 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (CG)
Number of subjects: 221
Study 33060415 — intervention group
Group type: EXPERIMENTAL
Intervention: Soap and water
Number of subjects: 100
Study 33060415 — intervention group
Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol swab
Number of subjects: 100
Study 33060415 — intervention group
Group type: EXPERIMENTAL
Intervention: Makeup removal wipe
Number of subjects: 100
Study 32826776 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Health model for chronic pain care
Number of subjects: 74
Study 32826776 — intervention group
Group type: EXPERIMENTAL
Intervention: Local adaptations through formative evaluation
Number of subjects: 74